Clinical Scorecard: A Case Study of SAPHO Syndrome Associated with Membranous Nephropathy and Analgesic-Induced Kidney Injury
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Primarily women aged 30–50 years, but also includes men as evidenced by the case study.
Care Setting
Key Highlights
Treatment included intravenous cefuroxime sodium, methylprednisolone, and oral mycophenolate mofetil, leading to symptom resolution.
Guideline-Based Recommendations
Diagnosis
Management
Standardized treatment with mannitol, sodium aescinate, and corticosteroids, along with supportive care and monitoring.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Intravenous cefuroxime sodium, methylprednisolone, and oral mycophenolate mofetil were used, targeting both infection and inflammation.
Clinical Best Practices
Monitor renal function in patients with SAPHO syndrome showing signs of nephropathy, and consider differential diagnosis with IgA nephropathy, lupus nephritis, and other inflammatory disorders.
